- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02053688
Evaluation Study on Corneal Lens for Vision Correction
February 2, 2014 updated by: FORSIGHT Vision3
The objective of this study is to evaluate the fitting and visual outcomes of Nexis Lens, made of silicone commonly used in the contact lens industry, on healthy eye with or without astigmatism.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Fremont, California, United States, 94538
- Cliff Leong
-
Fremont, California, United States, 94538
- Sara Chiu
-
Livermore, California, United States, 94550
- John Michelsen
-
Menlo Park, California, United States, 94025
- Nexis Vision
-
San Mateo, California, United States, 94401
- Nick Chan
-
Stockton, California, United States, 95219
- Josephine Vo-Laurel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient with good corneal health
- Age 18-65.
- Patients able to understand the requirements of the study and willing to follow study instructions, to provide written informed consent to participate, and who agree to comply with all study requirements.
- Best corrected visual acuity of 20/20 or better in the study eye/s
Exclusion Criteria:
- Any other anterior segment abnormality.
- No previous corneal procedures, including Laser Vision Correction.
- Any abnormalities associated with the eye lids.
- Clinically significant inflammation or infection within six (6) months prior to study.
- Uncontrolled systemic disease (e.g., diabetes, hypertension, etc.) in the opinion of the Investigator.
- Participation in any study involving an investigational drug or device within the past 30 calendar days, or ongoing participation in a study with an investigational material except studies using corneal lenses.
- Intolerance or hypersensitivity to topical anesthetics, fluorescein, or components of the material.
- Specifically known intolerance or hypersensitivity to contact lenses.
- Any condition that, in the opinion of the investigator, would jeopardize the safety of the patient.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Astigmatic Correction Lens
Nexis ACCL lenses vs commercial Toric Lenses
|
Astigmatic refractive error correction
|
Active Comparator: Toric Soft Contact Lenses
commercial toric soft contact lenses
|
astigmatism correction using toric optics
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Visual Acuity
Time Frame: 30 mins
|
30 mins
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ashley Tuan, OD, PhD, Nexisvision
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (Actual)
November 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
January 30, 2014
First Submitted That Met QC Criteria
February 2, 2014
First Posted (Estimate)
February 4, 2014
Study Record Updates
Last Update Posted (Estimate)
February 4, 2014
Last Update Submitted That Met QC Criteria
February 2, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CL001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Ohio State UniversityCompletedAstigmatism BilateralUnited States
-
Coopervision, Inc.Completed
-
Cairo UniversityUnknown
-
Assiut UniversityCompleted
-
Ashford and St. Peter's Hospitals NHS TrustBausch & Lomb IncorporatedUnknown
-
Carl Zeiss Meditec, Inc.CompletedMixed AstigmatismUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Ziemer Ophthalmic Systems AGTigermed Consulting Co., LtdRecruitingMyopic AstigmatismChina
-
Bausch & Lomb IncorporatedCompleted
-
Staar Surgical CompanyActive, not recruiting
Clinical Trials on Astigmatic Correction Lens (Nexis ACCL lenses)
-
Coopervision, Inc.CompletedAstigmatismUnited Kingdom